These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
156 related items for PubMed ID: 1458151
1. [A comparative study of the psychotropic activity of different salts of homopantothenic acid]. Karaev AL, Kovler MA, Avakumov VM. Eksp Klin Farmakol; 1992; 55(3):11-4. PubMed ID: 1458151 [Abstract] [Full Text] [Related]
7. [Place of neurometabolic stimulators (cerebroprotectors) in the current systematics of psychotropic drugs and their principal kinds of clinical activity]. Niss AI. Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(5):750-6. PubMed ID: 6464593 [Abstract] [Full Text] [Related]
8. [Psychotropic effects of alkaloid lappaconitine and its various derivatives]. Tolstikova TG, Voevoda TV, Dolgikh MP. Eksp Klin Farmakol; 2001; 64(4):7-9. PubMed ID: 11589117 [Abstract] [Full Text] [Related]
10. [Recent advances in brain metabolic activators]. Ohtomo E. No To Shinkei; 1984 Jul; 36(7):619-32. PubMed ID: 6386014 [No Abstract] [Full Text] [Related]
11. [A comparative study of the permeability across the hemato-encephalic barrier and of the effect on cerebral blood flow of the new neurotropic agent calcium ketohomopantothenate and of pantogam]. Nasybullina NM, Gunar VI, Zherdev VP, Sariev AK, Kozlova GS, Mirzoian RS, Gan'shina TS, Karaev AL. Eksp Klin Farmakol; 1997 Jul; 60(2):58-61. PubMed ID: 9206573 [Abstract] [Full Text] [Related]
12. Intracranial self-stimulation and locomotor traces as indicators for evaluating the homopantothenic acid. Takigawa M, Ueyama K, Fukuzako H, Maeda H, Matsumoto K. Jpn J Psychiatry Neurol; 1993 Dec; 47(4):915-20. PubMed ID: 8201803 [Abstract] [Full Text] [Related]
13. [Characteristics of the psychotropic effects of N-crown ether derivatives]. Timofeeva SE, Voronina TA, Karaseva TL, Golovenko NIa, Garibova TL. Farmakol Toksikol; 1986 Dec; 49(4):13-5. PubMed ID: 2944762 [Abstract] [Full Text] [Related]
14. [Therapeutic application of cerebral metabolism enhancers to Alzheimer's disease and their limitations]. Hasegawa K. Nihon Rinsho; 1988 Jul; 46(7):1575-9. PubMed ID: 3221465 [No Abstract] [Full Text] [Related]
17. [The effect of calcium pantothenate and homopantothenate on [14C]-GABA absorption by slices of rat cerebral cortex]. Reĭtarova TE, Rozanov VA, Kovler MA, Kopelevich VM, Totskiĭ VN. Farmakol Toksikol; 1988 Jul; 51(4):25-9. PubMed ID: 3191967 [Abstract] [Full Text] [Related]
18. [Mechanism of pantogam potentiation of certain effects of hexobarbital and sodium barbital and inhibition of phenamine hyperactivity]. Avakumov VM, Kovler MA. Farmakol Toksikol; 1981 Jul; 44(1):30-4. PubMed ID: 7262297 [Abstract] [Full Text] [Related]
19. Pantoyl-gamma-aminobutyric acid facilitates cholinergic function in the central nervous system. Nakahiro M, Fujita N, Fukuchi I, Saito K, Nishimura T, Yoshida H. J Pharmacol Exp Ther; 1985 Feb; 232(2):501-6. PubMed ID: 2982013 [Abstract] [Full Text] [Related]
20. Effect of gamma-aminobutyric acid derivatives, especially homopantothenic acid, on the excitability of the brain. Nishizawa Y, Kodama T, Tsujino G. J Vitaminol (Kyoto); 1968 Dec 10; 14(4):331-44. PubMed ID: 5715258 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]